Open-source automated insulin delivery systems, commonly referred to as do-it-yourself
automated insulin delivery systems, are examples of user-driven innovations that were co …

Context Hypoglycemia in people with diabetes is common, especially in those taking
medications such as insulin and sulfonylureas (SU) that place them at higher risk …

Background Hybrid closed-loop insulin therapy has shown promise for management of type
1 diabetes during pregnancy; however, its efficacy is unclear. Methods In this multicenter …

Objective To provide evidence-based recommendations regarding the use of advanced
technology in the management of persons with diabetes mellitus to clinicians, diabetes-care …

Background: Time in range (TIR) is an emerging metric of glycemic control and is reported to
be associated with microvascular complications of diabetes. We sought to investigate the …

Recent upswings in the use of continuous glucose monitoring (CGM) technologies have
given people with diabetes and healthcare professionals unprecedented access to a range …

Abstract The International Consensus in Time in Range (TIR) was recently released and
defined the concept of the time spent in the target range between 70 and 180 mg/dL while …

Automated insulin delivery (AID) systems have established benefits in terms of glycemic
control, health outcomes, and quality of life and are strongly recommended for people with …

OBJECTIVE Continuous glucose monitoring (CGM) improves maternal glycemic control and
neonatal outcomes in type 1 diabetes pregnancies compared with self-monitoring of blood …

Optimal glycemic control remains challenging and elusive for many people with diabetes.
With the comprehensive clinical evidence on safety and efficiency in large populations, and …